Endocyte
Get Full AccessDescription
- Endocyte is a biopharmaceutical company developing targeted therapies for the treatment of cancer and other serious diseases. Endocyte uses its proprietary technology to create novel SMDCs and companion imaging diagnostics for personalized targeted therapies. The company's SMDCs actively target receptors that are over-expressed on diseased cells, relative to healthy cells. This targeted approach is designed to enable the treatment of patients with highly active drugs at greater doses, delivered more frequently and over longer periods of time than would be possible with the untargeted drug alone. The companion imaging diagnostics are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment.
-
Headquarters:3000 Kent Avenue , West Lafayette, Indiana, United States
More -
Phone Number: +1 765-463-7175
-
Website: https://www.endocyte.com
-
Employees:49
-
Revenue:$10 - 50M
-
Legal Name:Endocyte
-
Endocyte's Social Media
-
Is this data correct?
-
| NAICS Code: 541715 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Endocyte
-
Where are Endocyte's Headquarters?
Endocyte's Headquarters are in 3000 Kent Avenue ,West Lafayette,Indiana,United States
-
What is Endocyte's phone number?
Endocyte's phone number is +1 765-463-7175
-
What is Endocyte's official website?
Endocyte's official website is https://www.endocyte.com
-
What is Endocyte's Revenue?
Endocyte's revenue is $10 - 50M
-
What is Endocyte's NAICS code?
Endocyte's NAICS code is 541715
-
How many employees are working in Endocyte
Endocyte has 49 employees
-
What is Endocyte's Industry?
Endocyte is in the industry of Pharmaceuticals
-
Who is Endocyte's Vice President Of Discovery Chemistry?
Endocyte's Vice President Of Discovery Chemistry is Iontcho Vlahov